UPDATE 1-OncoGenex seeks strategic alternatives after drug study fails
Aug 16 (Reuters) - OncoGenex Pharmaceuticals Incsaid it was exploring strategic alternatives after its
experimental drug failed to show survival benefit in a
late-stage study in patients with...
Read more »